Left ventricular diastolic dysfunction in patients with heart failure with mildly reduced ejection fraction

被引:3
|
作者
Abel, Noah [1 ]
Schupp, Tobias [1 ]
Schmitt, Alexander [1 ]
Reinhardt, Marielen [1 ]
Lau, Felix [1 ]
Weidner, Kathrin [1 ]
Ayoub, Mohamed [2 ]
Mashayekhi, Kambis [3 ]
Akin, Ibrahim [1 ]
Behnes, Michael [1 ]
机构
[1] Heidelberg Univ, Univ Med Ctr Mannheim, Med Fac Mannheim, Dept Cardiol Angiol Haemostaseol & Med Intens Care, D-68167 Mannheim, Germany
[2] Univ Bochum, Div Cardiol & Angiol, Heart Ctr, D-32545 Bad Oeynhausen, Germany
[3] MediClin Heart Ctr Lahr, Dept Internal Med & Cardiol, D-77933 Lahr, Germany
关键词
Heart failure with mildly reduced ejection; fraction; HFmrEF; Diastolic dysfunction; Mortality; EUROPEAN ASSOCIATION; PASSIVE STIFFNESS; RECOMMENDATIONS; ECHOCARDIOGRAPHY; PATHOPHYSIOLOGY; MECHANISMS; DISEASE;
D O I
10.1016/j.ijcard.2024.132386
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: This study investigates the prevalence and prognostic impact of diastolic dysfunction (DD) in patients hospitalized with heart failure (HF) with mildly reduced ejection fraction (HFmrEF) in sinus rhythm. Background: Data regarding the prognostic impact of DD in patients with HFmrEF is limited. Methods: From 2016 to 2022, all patients hospitalized with HFmrEF (i.e., left ventricular ejection fraction 41-49% and signs and/or symptoms of HF) were retrospectively included at one institution. Patients with DD were compared to patients without (i.e., non-DD), further risk stratification was performed according to the severity of DD. The primary endpoint was all-cause mortality at 30 months (interquartile range (IQR) 15-61 months), key secondary endpoint was rehospitalization for worsening HF. Results: From a total of 1154 patients (median age 68 years, 68% males) hospitalized with HFmrEF, concomitant DD was present in 72% (grade I: 56%, grade II: 14%, grade III: 2%). Patients with DD were older (71 years vs. 65 years; p = 0.001) and presented with higher rates of cardiovascular comorbidities. The presence of DD was not associated with the risk of long-term all-cause mortality (adjusted HR = 0.815; 95% CI 0.612-1.085; p = 0.161) or HF-related rehospitalization (adjusted HR = 0.736; 95% CI 0.442-1.225; p = 0.238). Furthermore, the outcome did not differ in patients with more advanced stages of DD. Conclusion: DD is commonly prevalent in patients with HFmrEF, but not associated with long-term prognosis.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Total 25-Hydroxyvitamin D Is an Independent Marker of Left Ventricular Ejection Fraction in Heart Failure with Reduced and Mildly Reduced Ejection Fraction
    Szabo, Timea Magdolna
    Nagy, Elod Erno
    Kirchmaier, Adam
    Heidenhoffer, Erhard
    Gabor-Kelemen, Hunor-Laszlo
    Frasineanu, Marius
    Cseke, Judit
    German-Sallo, Marta
    Frigy, Attila
    BIOMOLECULES, 2023, 13 (11)
  • [22] Left ventricular diastolic dysfunction and exercise intolerance in obese heart failure with preserved ejection fraction
    Samuel, T. Jake
    Kitzman, Dalane W.
    Haykowsky, Mark J.
    Upadhya, Bharathi
    Brubaker, Peter
    Nelson, M. Benjamin
    Hundley, W. Gregory
    Nelson, Michael D.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2021, 320 (04): : H1535 - H1542
  • [23] Dietary therapy in heart failure with preserved ejection fraction and/or left ventricular diastolic dysfunction in patients with metabolic syndrome
    von Bibra, Helene
    Stroehle, Alexander
    Sutton, Martin St John
    Worm, Nicolai
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 234 : 7 - 15
  • [24] Progression of impaired left ventricular contractility in patients with isolated diastolic dysfunction and heart failure with preserved ejection fraction
    Zhong, L.
    Poh, K. K.
    Sia, W.
    Lee, L. C.
    Le, T. T.
    Chua, T.
    Tan, R. S.
    EUROPEAN HEART JOURNAL, 2011, 32 : 615 - 615
  • [25] Association of Thrombin Generation with Left Ventricular Diastolic Dysfunction in Hypertensive Patients with Heart Failure with Preserved Ejection Fraction
    Ishiguro, Yuko S.
    Iida, Masato
    Yamamoto, Mitsuru
    Honjo, Haruo
    Kamiya, Kaichiro
    CIRCULATION, 2012, 126 (21)
  • [26] Effects of sacubitril/valsartan on left ventricular diastolic function in patients with chronic heart failure with reduced ejection fraction
    Ermacora, Davide
    Donazzan, Luca
    Casablanca, Simona
    Prinoth, Mara
    Schoepf, Elisabeth
    Bonsante, Edoardo
    Apuzzo, Elisa
    Ladurner, Carmen
    Bodini, Margherita
    Erlicher, Andrea
    Di Gaetano, Renato
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0J) : J127 - J127
  • [27] Phenotypic clusters and biomarkers profile in patients with chronic heart failure with preserved and mildly reduced left ventricular ejection fraction
    Dragomiretskaya, Natalia A.
    Tolmacheva, Anastasia V.
    Ivannikov, Alexander A.
    Shvedov, Ilya I.
    Belyakov, Artyom V.
    Agalarova, Kamila R.
    Podzolkov, Valery I.
    TERAPEVTICHESKII ARKHIV, 2024, 96 (12) : 1137 - 1143
  • [28] LEFT VENTRICULAR DIASTOLIC FUNCTION IN HYPERTENSIVE PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION
    Zhemanyuk, Svitlana
    Syvolap, Vitaliy
    JOURNAL OF HYPERTENSION, 2024, 42 (SUPPL 3)
  • [29] Aldosterone blockade in patients with heart failure and a reduced left ventricular ejection fraction
    Pitt, Bertram
    EUROPEAN HEART JOURNAL, 2009, 30 (04) : 387 - 388
  • [30] Treatment of Heart Failure with Reduced Left Ventricular Ejection Fraction
    Aronow, W. S.
    CURRENT ADVANCES IN HEART DISEASE, 2008, : 277 - 280